Lineage Cell Therapeutics Stock Forecast

Buy candidate since Jun 26, 2026 Gain 3.13%

The Lineage Cell Therapeutics, Inc. stock price fell by -0.752% on the last day (Tuesday, 7th Jul 2026) from $1.33 to $1.32. During the last trading day the stock fluctuated 3.86% from a day low at $1.30 to a day high of $1.35. The price has fallen in 6 of the last 10 days but is still up by 4.76% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -155 thousand shares and in total, 680 thousand shares were bought and sold for approximately $897.42 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.37 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -22.07% during the next 3 months and, with a 90% probability hold a price between $0.83 and $1.07 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

LCTX Signals & Forecast

The Lineage Cell Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.32 and $1.26. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 10.92%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Lineage Cell Therapeutics, Inc. stock

Lineage Cell Therapeutics, Inc. finds support from accumulated volume at $1.31 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0500 between high and low, or 3.86%. For the last week the stock has had daily average volatility of 4.46%.

Our recommended stop-loss: $1.24 (-5.82%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (LCTX) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Lineage Cell Therapeutics, Inc. to open at $1.32, and during the day (based on 14 day Average True Range), to move between $1.29 and $1.35, which gives a possible trading interval of +/-$0.0670 (+/-5.21%) up or down from last closing price. If Lineage Cell Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.33 (0.76%) than the support at $1.31 (0.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Lineage Cell Therapeutics, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term.

Current score: 3.062 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $1.32 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk